Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Medmix AG's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was CHF9.646. Medmix AG's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is CHF0.00.
As of today (2026-07-31), Medmix AG's share price is CHF8.535. Medmix AG's Median PS Value is CHF0.00. Therefore, Medmix AG's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Medmix AG's Median PS Value or its related term are showing as below:
CHIX:MEDXz's Price-to-Median-PS-Value is not ranked *
in the Industrial Products industry.
Industry Median: 1.09 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Medmix AG (CHIX:MEDXz) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Medmix AG's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
8.535
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG Median PS Value Related Terms
Medmix AG Median PS Value Historical Data
* Premium members only.
The historical data trend for Medmix AG's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:MEDXZ vs GEV, ETN, PH: Median PS Value Comparison
For the Specialty Industrial Machinery subindustry, Medmix AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG Price-to-Median-PS-Value vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Medmix AG's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medmix AG's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was CHF9.646.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG (CHIX:MEDXZ) has a Median PS Value of CHF0.00 as of Jul. 31, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Medmix AG and its competitors. According to the industry distribution chart, Medmix AG ranks #999999 out of 1642 companies in the Industrial Products industry.
Is Medmix AG's Median PS Value too high?
Medmix AG's current Median PS Value is CHF0.00. Based on the distribution chart, Medmix AG ranks #999999 out of 1642 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Medmix AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Median PS Value compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #999999 out of 1642 companies for Median PS Value. This places Medmix AG in the lower half of its industry. The industry median Median PS Value is 1.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for an Industrial Products company?
The median Median PS Value among Industrial Products companies is 1.09, based on 1,642 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median Median PS Value is 1.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current Median PS Value is CHF0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.05, compared to a current price of CHF8.54 — trading 5.7% below its estimated fair value. The current Median PS Value is CHF0.00. Medmix AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current Median PS Value is CHF0.00 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of CHF8.54 is trading 5.7% below its estimated GF Value™ of CHF9.05.
GuruFocus considers Medmix AG to be Fairly Valued.
Key valuation signals for CHIX:MEDXZ:
Median PS Value: CHF0.00
GF Value™: CHF9.05 vs. price of CHF8.54 (5.7% below fair value)
No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
66GF Score
Get the complete analysis for CHIX:MEDXZ
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:MEDXZ has been successfully added to your 
